Bookmark and Share
BioAssay: AID 540271

In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity

Assay Overview: During its life cycle in its human host P. falciparum infects and remodels red blood cells. Strikingly, P. falciparum also shows a marked expansion of the heat shock protein 40 (Hsp40) family of co-chaperones and it has been proposed that during this process the parasite relies on a greatly expanded class of Hsp40 co-chaperones to infect and kill cells. In this screening more ..
_
   
 Tested Compounds
 Tested Compounds
All(826)
 
 
Active(485)
 
 
Inactive(338)
 
 
Inconclusive(3)
 
 
 Tested Substances
 Tested Substances
All(826)
 
 
Active(485)
 
 
Inactive(338)
 
 
Inconclusive(3)
 
 
AID: 540271
Data Source: Broad Institute (2120-01_Inhibitor_Dose_CherryPick_Activity)
BioAssay Type: Confirmatory, Concentration-Response Relationship Observed
Depositor Category: NIH Molecular Libraries Probe Production Network
Deposit Date: 2011-07-18

Data Table ( Complete ):           View Active Data    View All Data
Target
BioActive Compounds: 485
Related Experiments
AIDNameTypeComment
504552Broad Institute Identification of malaria Hsp40 chaperone inhibitors in yeast Inhibitor Probe ProjectSummarydepositor-specified cross reference: Summary assay
504582In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_ActivityScreeningsame project related to Summary assay
624258In vivo-based yeast HTS counterscreen to detect compounds rescuing yeast growth/survival of Saccharomyces cerevisiae SKN7-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-02_Inhibitor_Dose_CherryPick_ActivityConfirmatorysame project related to Summary assay
624265Mammalian cell toxicity counterscreen to identify toxic HSP40 inhibitor compounds in NIH3T3 cells Measured in Cell-Based System Using Plate Reader - 2120-03_Inhibitor_Dose_CherryPick_Activity_Set2Confirmatorysame project related to Summary assay
652041Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_ActivityConfirmatorysame project related to Summary assay
652047Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_ActivityConfirmatorysame project related to Summary assay
Description:
Keywords: Heat shock proteins, malaria

Assay Overview: During its life cycle in its human host P. falciparum infects and remodels red blood cells. Strikingly, P. falciparum also shows a marked expansion of the heat shock protein 40 (Hsp40) family of co-chaperones and it has been proposed that during this process the parasite relies on a greatly expanded class of Hsp40 co-chaperones to infect and kill cells. In this screening project, the capacity of small molecules to block malaria HSP40-mediated yeast toxicity and induce yeast growth will be measured through luminescence mediated by the presence of intracellular ATP in yeast as an indicator of cell viability.

Expected Outcome:Identification of probe(s) inhibiting malaria HSP40-mediated yeast toxicity . Compounds with an AbsAC1000 (Absolute active concentration at an arbitrary value of 1000) below 10 uM will be considered hits.
Protocol
Malaria HSP40 Growth Rescue Assay Protocol:

Day 1 (overnight growth culture):

1. Thaw vial containing Saccaromyces cerevisiae W303a Dpdr1, Dpdr3 pAG426GPD-Plasmodim falciparum Hsp40 (PFE0055C) yeast glycerol stock (Provided by Dr. Susan Lindquist's lab) in 20 ml SRaff-Ura media (recipe below) and grow yeast overnight at 23 degree C with shaking.
Day 2 (Yeast Plating)

2. Check OD600 to ensure culture remains in log phase (OD600 0.2-0.8) until ready to use for plating in assay format.

3. After taking the OD at 600nm, dispense 6 ul of PFE 426 yeast at OD (600 nm) of 0.015 in SGal-Ura using multidrop dispenser (Thermo Scientific) with small tubing cassette (Thermo Scientific) in assay ready 1536-well black plates (Aurora, cat #00019180BK) with compound already present in the well (7.5 nl) 8 concentrations, 3 fold dilution (starting concentration 10 mM).

4. Incubate plates at 30 degree C for 3 days in humidified environment.

Day 3 (Adding Bactiter-Glo reagent and Reading on Envision)

5. Add 2 ul Bactiter-Glo (Promega, G8233) using multidrop dispenser (small tubing cassette)(Thermo Scientific). Read immediately luminescence (ultrasensitive setting) on Envision.

Media Preparation:
Overnight growing media (SRaff-Ura):
1.7 g Yeast Nitrogen Base (YNB) media without amino acids, without ammonium sulfate (Sigma, Cat #Y1251)0.77g CSM-Ura drop-out powder (Sunrise Science Products, Catalog #1004-100)1g L-Glutamic acid, monosodium salt(Sigma #G1626)20g raffinose (Sigma, Cat #R0250)1L H20

Screen media (SGal-Ura):1.7 g Yeast Nitrogen Base (YNB) without amino acids, without ammonium sulfate (Sigma, Cat#Y1251)0.77g CSM-Ura drop-out powder (Sunrise Science Products, catalog #1004-100)1g L-Glutamic acid, monosodium salt (Sigma #G1626)20g D(+) galactose (Sigma, Cat #G5388)1L H20

Positive control media (SGlu-Ura):1.7 g Yeast Nitrogen Base YNB without amino acids, without ammonium sulfate (Sigma, Cat #Y1251)0.77g CSM-Ura drop-out powder (Sunrise Science Products, catalog #1004-100)1g L-Glutamic acid, monosodium salt (Sigma #G1626)20g glucose (Sigma, G7528)1L H20
Stir for 30-60 mins at RTFilter into 0.2 uM filter flaskKeep media at room temperature until use within 2 months.
Comment
PRESENCE OF CONTROLS: Neutral control wells (NC; n=288) were included on every plate.

EXPECTED OUTCOME: Active compounds result in increasing readout signal.

ACTIVE CONCENTRATION LIMIT:
For each sample, the highest valid tested concentration (Max_Concentration) was determined and the active concentration limit (AC_limit) was set to equal Max_Concentration.

NORMALIZATION:
The raw signals of the plate wells were normalized using the 'Neutral Controls' method in Genedata Assay Analyzer (v7.0.3):
The median raw signal of the intraplate neutral controls (NC) is set to a normalized activity value of 0.
A normalized activity value of 100 is defined as (2)(NC).
A normalized activity value of -50 is defined as (0.5)(NC).
Experimental wells values were scaled to this range.

PATTERN CORRECTION: No plate pattern correction algorithm from Genedata Condoseo (v.7.0.3) was applied.

MEASUREMENT USED TO DETERMINE ACTIVE CONCENTRATION (AC): absACnn, the concentration at which the curve crosses threshold 1000.0
AC values were calculated using the curve fitting strategies in Genedata Screener Condoseo (7.0.3).
AC values were calculated up to the active concentration limit described for each sample.
pAC was set to equal -1*log10(AC)

PUBCHEM_ACTIVITY_OUTCOME:
Activity_Outcome = 1 (inactive) when:
a) compound shows activity but in a direction opposite to the expected outcome
in these cases, values describing curve fitting parameters (Sinf, S0, Hill Slope, log_AC50, log_AC50_SE) are set to null
b) curve fit is constant where activity is > -30% and < 30% at all tested concentrations, or
c) AC > AC_limit
Activity_Outcome = 2 (active) when:
AC <= AC_limit
Activity_Outcome = 3 (inconclusive) when:
a) Curve fitting strategy resulted in a constant fit with activity >= 30% but <= 70%, or
b) The fit was deemed not valid due to poor fit quality.

PUBCHEM_ACTIVITY_SCORE:
If PUBCHEM_ACTIVITY_OUTCOME = 1 (inactive) or 3 (inconclusive),
then PUBCHEM_ACTIVITY_SCORE = 0
If PUBCHEM_ACTIVITY_OUTCOME = 2 (active)
then PUBCHEM_ACTIVITY_SCORE = (10)(pAC)
Scores relate to AC in this manner:
120 = 1 pM
90 = 1 nM
60 = 1 uM
30 = 1 mM
0 = 1 M
When the active concentration (AC) is calculated to be greater than the highest valid tested concentration (Max_Concentration), the PUBCHEM_ACTIVITY_SCORE is calculated using Max_Concentration as the basis.
When the active concentration (AC) is calculated to be less than the lowest tested concentration, the PUBCHEM_ACTIVITY_SCORE is calculated using the lowest tested concentration as the basis.

Note:
The individual dose data point columns ('Activity_at_xxuM') reported here represent the median of valid (unmasked) replicate observations at each concentration. These values are the inputs to a curve fitting algorithm.
All other data columns represent values which are derived during the curve fitting algorithm; this may sometimes include automatic further masking of some replicate data points.
Occasionally this results in perceived inconsistencies: for example, between the derived 'Maximal_Activity' and the apparent most active data point.
Categorized Comment - additional comments and annotations
From PubChem:
Assay Format: Organism-based
Assay Type: Toxicity
Assay Test Type: In vivo
From ChEMBL:
Assay Format: Organism-based
Assay Type: Functional
Result Definitions
Show more
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1AbsAC1000_Qualifier<, =, or >String
2AbsAC1000_uM*The concentration at which the fitted curve passes activity threshold 1000.FloatμM
3pAbsAC1000_MEqual to -1*log10(AbsAC1000).Float
4Hill_SlopeThe slope at AC50Float
5S0_(%)The fitted activity value at zero concentrationFloat%
6Sinf_(%)The fitted activity value at infinite concentrationFloat%
7Num_PointsThe number of data points used to generate the plotInteger
8Max_Activity_(%)The maximum activity value observed, based on mean of replicates per concentrationFloat%
9Max_Activity_Conc_uMThe concentration at which the maximum activity is observedFloatμM
10Max_Concentration_uMMaximum valid test concentrationFloatμM
11Activity_at_0.0056uM_(%) (0.0056μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
12Activity_at_0.018uM_(%) (0.018μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
13Activity_at_0.05uM_(%) (0.05μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
14Activity_at_0.15uM_(%) (0.15μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
15Activity_at_0.46uM_(%) (0.46μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
16Activity_at_1.35uM_(%) (1.35μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
17Activity_at_4.2uM_(%) (4.2μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
18Activity_at_12uM_(%) (12μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%

* Activity Concentration. ** Test Concentration.
Additional Information
Grant Number: 1 R03 DA031664-01

Data Table (Concise)
Data Table ( Complete ):     View Active Data    View All Data
PageFrom: